Savannah Koplon

Savannah Koplon

| This email address is being protected from spambots. You need JavaScript enabled to view it.

Public Relations Manager, Health and Medicine

skoplon@uab.edu • (205) 641-1211

Leads external communications in healthcare, biomedical research and for UAB's six professional schools; Dentistry, Health Professions, Medicine, Nursing, Optometry and Public Health. Koplon and her team proactively tell the story of UAB health and medicine, including patient stories, innovative research and new therapies, through original content and extensive collaborations with local, national and international media. The team works reactively to ensure appropriate experts are connected with media within their deadline.

Specific beats include: Health System Administration; Heersink School of Medicine (Administration, Student News, Education); Issues Management; Medical Facilities; Medical Partnerships; Precision Medicine; Infectious Diseases; Emergency Medicine; Civitan International Research Center; CCTS;  Department of Informatics; Department of Surgery (Transplantation, Xenotransplantation); Libraries (Reynolds Historical Library, Alabama Museum of the Health Sciences, Lister Hill library)

UAB will continue to lead the National Dental Practice-Based Research Network.
UAB is a leading site in the administration of intranasal esketamine. How will this impact the care of patients with depression in the future?
The grant will enable researchers to evaluate the complement system at the ocular surface in those with pSS dry eye disease.
Different systemic eye conditions impact the way many student athletes are able to play sports in direct sunlight. One helmet addition now approved thanks to UAB could help.
For mothers with substance abuse disorders, UAB is helping to provide crucial care for them and their child.
Dr. Aman Wadhwa has received a generous St. Baldrick’s Foundation grant.
UAB researcher uses the tree shrew as a model for the study of dry eye disease.
Researchers are spearheading efforts to understand the development of treatment-related health conditions in the context of accelerated aging.
In a new trial led by the NIH, researchers will evaluate whether a long-acting medication will be beneficial for patients who are not normally consistent with medication.
Taylor Phillips is UAB’s first OD/MBA graduate.
Page 29 of 45